Natalie Arnold: Germany Recognizes Low-Dose Colchicine in CVD Prevention
Natalie Arnold, Preventive Cardiologist at University Heart and Vascular Center Hamburg, shared a post on LinkedIn:
“Great news from Germany for anti-inflammatory therapy in CVD!
Today, the German Federal Joint Committee (G-BA) officially recognized an indication of additional benefit for low-dose colchicine in the secondary prevention of ischemic CV events, as an add-on to standard therapy.
In these turbulent times for anti-inflammatory therapies in cardiovascular disease, this decision extends beyond colchicine.
It supports the clinical relevance of targeting inflammation as part of residual-risk reduction and marks an important step toward translating this concept into cardiovascular care.
On a personal note, it was an absolute honor to lead together with Prof. Wolfgang Koenig, the interdisciplinary joint statement submitted by the German Cardiac Society (DGK), the German Society of Nephrology (DGfN), the German Society of Internal Medicine (DGIM), and the German Society for Prevention and Rehabilitation of Cardiovascular Diseases (DGPR) for this benefit-assessment procedure.
A huge thank you to all co-authors: Prof. Stephan Gielen, Prof. Ingo Hilgendorf, Prof. Bernd Nowak, Prof. Bernd Nowak, Prof. Harm Wienbergen , Prof. Peter R. Mertens , Prof. Christoph Wanner, Prof. Georg Ertl, Prof. Tilman Sauerbruch and Prof. Bernhard Schwaab – for their expertise, commitment and collegiality.
This is more than a regulatory decision – it is a meaningful step toward making inflammation an actionable target in cardiovascular prevention.”
Stay updated with Hemostasis Today.
-
Aug 25, 2026, 11:48GPAS 2026 Advancing Access and Equity in Bleeding Disorders – WFH
-
Aug 25, 2026, 11:41Gregory Lip: Don’t Miss – €1,000 Mechanical Thrombectomy Grant
-
Aug 25, 2026, 11:35Applications Now Open for ASH26 Scientific Workshops
-
Aug 25, 2026, 11:34Louise St. Germain Bannon: ISTH is Looking for a Director of Strategic Partnerships and Business Development
-
Aug 25, 2026, 11:25Wolfgang Miesbach: Haemophilia and Ageing – A Joint ISTH/EAHAD Session at ISTH 2026
-
Aug 25, 2026, 11:18Caitlin Raymond: Your Blood Type Doesn’t Define Your Personality
-
Aug 25, 2026, 11:18N. Mariana S. Vasquez: USMLE Key Differences – Marfan Syndrome vs. Homocystinuria
-
Aug 25, 2026, 11:16Miguel Bronchud: Making Monoclonal Antibodies Safer in Pregnancy
-
Aug 25, 2026, 11:08William Aird: Iron Deficiency vs. Inflammation – Look at the Minivans